The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cost-effectiveness of FOLFIRI + cetuximab vs FOLFIRI + bevacizumab in the first-line treatment of RAS wild-type (wt) metastatic colorectal cancer (mCRC) in Germany: Data from the FIRE-3 (AIO KRK-0306) study.
 
Sebastian Stintzing
Honoraria - Amgen; Bayer; Lilly; Merck KGaA; Roche; Sanofi; Sirtex Medical
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Lilly; Merck KGaA; Roche; Sanofi
Travel, Accommodations, Expenses - Amgen; Bayer; Lilly; Merck KGaA; Roche; Sanofi; Sirtex Medical
 
Ilse van Oostrum
Consulting or Advisory Role - AstraZeneca; Johnson & Johnson; Merck KGaA; Pfizer
 
Chris Pescott
Employment - Merck KGaA
 
Alma Katharina Steinbach-Buechert
Employment - Merck Serono
 
Bart Heeg
Consulting or Advisory Role - AstraZeneca; Johnson & Johnson; Merck; Pfizer; UCB
Research Funding - AstraZeneca; Johnson & Johnson; Merck; Pfizer; UCB
 
Volker Heinemann
Honoraria - Amgen; Baxalta; Celgene; Merck; Roche; Sanofi; Sirtex Medical
Consulting or Advisory Role - Amgen; Baxalta; Boehringer Ingelheim; Celgene; Merck; Roche; Sanofi; Sirtex Medical
Research Funding - Amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); IntegraGen (Inst); Merck (Inst); Roche (Inst); Sanofi (Inst); Sirtex Medical (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Amgen; Baxalta; Merck; Roche; Sirtex Medical